Bigul

Medico Intercontinental Ltd - 539938 - Request For Change In Details Under 'Corporate Information Tab' On The Website Of BSE.

Dear Sir/Ma'am, With respect to above mentioned subject and pursuant to earlier outcome given on 28th May, 2022 and our earlier letters provided dated 10th May, 2019 and 13th December, 2019, we would like to request you to kindly update Corporate Information Tab of our Company on the website of BSE. Please update the changes as per attached PDF. Kindly update the same in your records, so that the same can be disseminated to the Company's stakeholders. Thanking You
27-06-2022
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sir / Ma'am, We hereby wish to inform you that the Audited financial results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2022 were approved at the meeting of Board of Directors held on Saturday, 28th May, 2022. In continuation to the same, the newspaper clipping duly published in English and Gujarati Newspaper is enclosed herewith. This is for your information and records.
30-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In Respect Of Related Party Disclosures.

As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2022, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 7,65,20,109/- (Rupees Seven Crores Sixty Five Lakhs Twenty thousand One Hundred and Nine only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
28-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Results - Financial Year Ended 31St March 2022

Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 28, 2022 as per attached PDF. The Board Meeting of the Company commenced at 11:45 AM and concluded at 03:20 PM. This is for your information and records.
28-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., May 28, 2022 as per the PDF attached. The Board Meeting of the Company commenced at 11:45 AM and concluded at 03:20 PM. This is for your information and records.
28-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Non - Applicability of provisions of Reg. 24A of SEBI (LODR), Regulations- relating to Annual Secretarial Compliance Report for the year ended 31st March, 2022.
28-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 28th May, 2022 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended 31st March, 2022 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
21-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Reply To The Clarification Sought By Stock Exchange

With reference to your email dated 11/05/2022, we wish to inform you that the Company has made all the necessary disclosures pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has not withheld any material information/event that in our opinion would have bearing on the price/volume behavior of the scrip. The Company shall continue to make applicable disclosures, within the stipulated time. Therefore, the increase in the share price / volume of the company is purely due to market conditions and absolutely market driven and the management of the company is in no way connected with any such increase in price / volume. You are requested to take the same on record.
12-05-2022
Bigul

Medico Intercontinental Ltd - 539938 - Clarification sought from Medico Intercontinental Ltd

The Exchange has sought clarification from Medico Intercontinental Ltd on May 11, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
12-05-2022
Next Page
Close

Let's Open Free Demat Account